Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Change in Inventory (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Change in Inventory readings, the most recent being -$5.4 million for Q4 2025.

  • On a quarterly basis, Change in Inventory fell 23.81% to -$5.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.2 million, a 132.21% decrease, with the full-year FY2025 number at -$3.2 million, down 132.21% from a year prior.
  • Change in Inventory hit -$5.4 million in Q4 2025 for Treace Medical Concepts, down from -$973000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $6.6 million in Q1 2024 to a low of -$5.4 million in Q4 2025.
  • Median Change in Inventory over the past 5 years was $2.1 million (2022), compared with a mean of $1.4 million.
  • Biggest five-year swings in Change in Inventory: surged 8745.16% in 2022 and later tumbled 6401.49% in 2024.
  • Treace Medical Concepts' Change in Inventory stood at $31000.0 in 2021, then surged by 8745.16% to $2.7 million in 2022, then plummeted by 102.44% to -$67000.0 in 2023, then tumbled by 6401.49% to -$4.4 million in 2024, then dropped by 23.81% to -$5.4 million in 2025.
  • The last three reported values for Change in Inventory were -$5.4 million (Q4 2025), -$973000.0 (Q3 2025), and $4.5 million (Q2 2025) per Business Quant data.